Wed, Jul 23, 2014, 9:53 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Genzyme Biosurgery (GZBX) Message Board

  • aghastone aghastone Oct 18, 2001 7:27 PM Flag

    Is Doyle Duke? or a relative?

    Truly, who can defend this terrible performance?

    Weighing the cash portion of the BXM purchase, adjusting for shares exchanged, this stock has gone from $23+ since the deal. Management has a clean slate in terms of stock price, since the basis disappeared in the merger.

    This is miserable performance by all but internet standards. Particularly in view of the 'umbrella' afforded by Genzyme General. On a stand alone basis, this company would have been in and through bankrupcy by now.

    Shameful.

    Where's the board? Same board as Genzyme General. May be time for shareholders to test the 'Genzyme Charter' with the SEC.

    Rating - the option "Disgusted" doesn't appear on Yahoo.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • aghastone,
      Please don't be offended by sockcats somewhat abusive response and don't be put off by the initials of the organization mentioned in his profile- its not what first comes to mind.
      Also, be aware that he has publicly submitted his real name and address on this message board and as such, you can NOT say or imply libelous or slanderous things about sockscats, because he is no longer a faceless, nameless chatter like the rest of us who only post here for entertainment.
      DUA

      • 1 Reply to diverseusall
      • Things never cease to amaze me on this thread. He says:

        "Also, be aware that he has publicly submitted his real name and address on this message board and as such, you can NOT say or imply libelous or slanderous things about sockscats, because he is no longer a faceless, nameless chatter like the rest of us who only post here for entertainment"

        Get real, DUA. If Sockscat has indeed posted his real name on this thread, that is his own deal and has nothing to do with the liability of other posters. Then again, you honestly thought that "Susan" could sue me over the advice I offered in reference to this stock, so I rest my case. A legal eagle you certainly are not, amigo.

    • First of all i agree with doyle that you must be rather pathetic to be concerned with stalking him onto other boards. Pretty sad.


      You are wrong when you say that gzbx would have been bankrupt by now. Gzbx has not recieved any financial benefit from that genzyme "umbrella" you are talking about. Financially they are functioning like a stand alone company in that they have to pay their own bills. None of their expenses have been met by genz. The reason genz and gzbx have the same board of directors is because either is a corporation but rather divisions of genzyme corp. The board of directors are for all of genzyme corp.


      I won't defend the performance of the stock. I have and will criticise top management for not buying some gzbx stock. We do however need to realize that the timing of this deal was horrible. The merger was announced right at the market high. We also need to understand the need for this merger. Each component had significant weaknesses that would have made it difficult to do much better had the merger not taken place.


      ................socks

    • What does having a sales force have to do with research and developement of gene therapies.

      Oh you just like to see your own words in print.

      How can you possibly defend that this company's performance is miserable except by internet standards?

      Oh you just like to see your own words in print.

      As to bankruptcy.

      Oh you just like to see your own words in print.

      Pathetic

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT